Men's Perceptions, Attitudes, and Knowledge Levels Toward Cancer Screening

Not Applicable

Not yet recruiting

• Conditions: Men's Health Screening; Cancer Screening

• Registration Number: NCT07087834
• Lead Sponsor: Pamukkale University

Brief Summary

Countries are establishing national and international cancer control programs in response to cancer, which has become a global problem. Therefore, cancer is a disease that can be combated not only through investments in treatment, but also through efforts focused on prevention and early diagnosis. According to GLOBOCAN 2022 data, more than 51% of all cancer cases worldwide occur in men. The three most common types of cancer in men are lung cancer, prostate cancer, and colorectal cancer. Increasing awareness, attitudes, and knowledge levels regarding cancer screenings, especially for preventable diseases, will increase participation in screening programs. Increased knowledge levels will translate into positive health behaviors. This study will be conducted as a randomized controlled trial to determine the effect of the Cancer Screenings Education for Men (CASEM) intervention on men's perceptions, attitudes, and knowledge regarding cancer screening programs. Research data will be collected at a public institution between September 2025 and September 2026. The study sample will consist of a total of 70 male individuals, including 35 experimental and 35 control groups that meet the inclusion criteria. Male individuals will be assigned to the experimental and control groups using stratified randomization. The Individual Identification Form, Cancer Screening Perception Scale, Cancer Screening Attitude Scale, and Cancer Screening Knowledge Scale will be used. IBM SPSS 29.0 software will be used to analyze the data obtained from the study. This study will be an important one that addresses Turkey's future vision within the scope of the Twelfth Development Plans and supports the goals and policy measures of the development plan. In addition, our study serves the Sustainable Development Goals, which are among the most important global goals in the context of sustainability. It is expected to have implications for health practices and planning.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-07
• Study First Submitted: 2025-07-04
• Study First Submitted QC: 2025-07-25
• Last Update Submitted: 2025-07-25
• Study First Posted: 2025-07-28
• Last Update Posted: 2025-07-28
• Study Start: 2025-09-01
• Primary Completion: 2025-09-30
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Male
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The change in the cancer screening perception of the experimental group according to the Cancer Screening Perception Scale scores at the end of the first and third month	3 months	It is a 26-item scale developed by Mahmood et al. (2016). Its validity and reliability in Turkish were established by Bozkurt and Yılmaz (2024). The scale items generally cover. The scale has five sub-factors: "Perceived Severity, Perceived Sensitivity, Perceived Benefits, Perceived Barriers, and Action Cues." The scale is a 6-point Likert scale (1 = Strongly disagree, 6 = Strongly agree). To prevent confusion, there is no "undecided" option. The scale is not aggregatable, and each sub-dimension in the scale is evaluated separately.
The change in the cancer screening attitude of the experimental group according to the Cancer Screening Attitude Scale scores at the end of the first and third month	3 months	The scale was developed by Yıldırım-Öztürk and colleagues (2020). The scale consists of 24 items and a single dimension. The scale is a five-point Likert scale. The items comprising the scale are answered on a scale ranging from 5 to 1, as follows: "5: I completely agree, 4: I somewhat agree, 3: I neither agree nor disagree, 2: I somewhat disagree, 1: I completely disagree." The scale is suitable for use on women and men aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic impairments that would prevent them from completing the scale.
The change in the cancer screening knowledge of the experimental group according to the Cancer Screening Knowledge Scale scores at the end of the first and third month	3 months	The scale was developed by Yıldırım-Öztürk and Uyar (2023). The scale consists of 25 items and 3 subscales. The subscales of the scale have not been specifically named. The first subscale of the scale consists of 10 items (items 8, 17-23, 25, and 28), the second subscale consists of 9 items (items 4, 5, 7, 10, 12, 13, 15, 16, and 27), and the third subscale has 6 items (items 1-3, 9, 11, 24). The scale is a three-point rating scale. The scale is answered on a scale from 1 to 3, with "1: Correct, 2: Incorrect, 3: I don't know." When calculating the scale score, "True" responses are scored as 1 point, while 'False' and "I don't know" responses are scored as 0 points. The lowest possible score on the scale is 0, and the highest possible score is 25. When calculating the scale score, the three items with negative meanings (Items 2, 11, and 24) must be reverse-coded. No cutoff point has been established for the scale score.

Secondary Outcome Measures

Name	Time	Method
Individuals' status regarding cancer screening in the final test conducted at the end of the third month after education	3 months	Both groups will be asked whether they conducted cancer screening in their final tests. A single-question survey will be administered, asking, "Have you had a cancer screening in the last three months?" Responses will be evaluated on a two-point Likert scale, with options for 'yes' and "no."

Trial Locations

Locations (1)

Pamukkale University; 🇹🇷 Denizli, Turkey